$0.38 -0.01 (-2.74%)

IGC Pharma, Inc. (IGC)

IGC Pharma, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies, including cannabinoid-based products. The company aims to leverage its research and development capabilities to address unmet medical needs in various therapeutic areas.

🚫 IGC Pharma, Inc. does not pay dividends

Company News

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
GlobeNewswire Inc. • Delveinsight • August 12, 2025

Over 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.

Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
Benzinga • Lisa Levin • July 6, 2023

Gainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company. Mullen Automotive, Inc. (NASDAQ: MULN) shares gained 52.8% to $0.2612 in pre-market trading. Mullen Automotive shares jumped 69% on Wednesday after the company announ...

4 High Volume Penny Stocks To Watch While The Stock Market Is Down
PennyStocks • J. Samuel • September 16, 2022

Penny stocks to buy? High volume has placed them on the watch list in the stock market today. The post 4 High Volume Penny Stocks To Watch While The Stock Market Is Down appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.